Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
66pct
8d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
Save Americans from the Fentanyl Emergency Act or the SAFE Act This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024. It limits the application of mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows a federal court to vacate or reduce the sentence for convictions of offenses involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II. The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2024 · fourth_quarter · Health Issues
H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, Substance Use Research Monitor the following: H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues Synthetic Fentanyl related issues Barriers to research resulting from DEA scheduling, Drug research related issues H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Xylazine related issues Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $20,000
Referred to the Subcommittee on Health.
Sponsor introductory remarks on measure. (CR H588)
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2024 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R.4531, Support for Patients and Communities Reauthorization Act, Reauthorization related issues Monitor the following: Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Mental Health Substance Use Disorder related issues H.R.467/S.1141, HALT Fentanyl Act, Entirety H.R.568, Save Americans from the Fentanyl Emergency (SAFE) Act, Entirety H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2024 · fourth_quarter · Alcohol and Drug Abuse
H.R.4531, SUPPORT Act, Reauthorization related issues Monitor the following: Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Mental Health Substance Use Disorder related issues Cannabidiol and Cannabis related issues H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety H.R.467/S.1141, HALT Fentanyl Act. Scheduling of Fentanyl related substances H.R.568, Save Americans from the Fentanyl Emergency "SAFE" Act, Entirety S.3921, Medicaid Bump Act, Entirety
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2024 · third_quarter · Health Issues
H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, Substance Use Research H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues Synthetic Fentanyl related issues Monitor the following: Barriers to research resulting from DEA scheduling, Drug research related issues H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Xylazine related issues Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2024 · third_quarter · Medical/Disease Research/Clinical Labs
Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Monitor the following: Mental Health Substance Use Disorder related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Reauthorization related issues; and Xylazine related issues H.R.467/S.1141, HALT Fentanyl Act, Entirety H.R.568, Save Americans from the Fentanyl Emergency (SAFE) Act, Entirety H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Alcohol and Drug Abuse
Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Monitor the following: Mental Health Substance Use Disorder related issues H.R.4531, SUPPORT Act, Reauthorization related issues Cannabidiol and Cannabis related issues H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety H.R.467/S.1141, HALT Fentanyl Act. Scheduling of Fentanyl related substances H.R.568, Save Americans from the Fentanyl Emergency "SAFE" Act, Entirety S.3921, Medicaid Bump Act, Entirety
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, Substance Use Research Monitor the following: Barriers to research resulting from DEA scheduling, Drug research related issues H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues Synthetic Fentanyl related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Xylazine related issues Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2024 · second_quarter · Medical/Disease Research/Clinical Labs
Mental Health Substance Use Disorder related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Reauthorization related issues; and Xylazine related issues Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Monitor the following: H.R.467/S.1141, HALT Fentanyl Act, Entirety H.R.568, Save Americans from the Fentanyl Emergency (SAFE) Act, Entirety H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Alcohol and Drug Abuse
Mental Health Substance Use Disorder related issues H.R.4531, SUPPORT Act, Reauthorization related issues Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Monitor the following: Cannabidiol and Cannabis related issues H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety H.R.467/S.1141, HALT Fentanyl Act. Scheduling of Fentanyl related substances H.R.568, Save Americans from the Fentanyl Emergency "SAFE" Act, Entirety S.3921, Medicaid Bump Act, Entirety
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, Substance Use Research Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, Substance Use Research Barriers to research resulting from DEA scheduling, Drug research related issues H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues Synthetic Fentanyl related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Xylazine related issues Monitor Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2024 · first_quarter · Alcohol and Drug Abuse
Mental Health Substance Use Disorder related issues H.R.4531, SUPPORT Act, Reauthorization related issues Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) S.3921, Medicaid Bump Act, Entirety Monitor the following: Cannabidiol and Cannabis related issues H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety H.R.467/S.1141, HALT Fentanyl Act. Scheduling of Fentanyl related substances H.R.568, Save Americans from the Fentanyl Emergency "SAFE" Act, Entirety
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Medical/Disease Research/Clinical Labs
Mental Health Substance Use Disorder related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Reauthorization related issues; and Xylazine related issues Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Monitor the following: H.R.467/S.1141, HALT Fentanyl Act, Entirety H.R.568, Save Americans from the Fentanyl Emergency (SAFE) Act, Entirety H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety Contingency Management, Protocol related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Health Issues
H.R.5894/S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, Substance Use Research Barriers to research resulting from DEA scheduling, Drug research related issues H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues Synthetic Fentanyl related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Xylazine related issues Monitor the following: Contingency Management, Protocol related issues Farm Bill 2023, Cannabidiol regulation
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2023 · fourth_quarter · Medical/Disease Research/Clinical Labs
Mental Health Substance Use Disorder related issues H.R.4531, Support for Patients and Communities Reauthorization Act, Reauthorization related issues; and Xylazine related issues Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Contingency Management, Protocol related issues Monitor the following: H.R.467/S.1141, HALT Fentanyl Act, Entirety H.R.568, Save Americans from the Fentanyl Emergency (SAFE) Act, Entirety H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety 2023 Farm Bill, Cannabidiol related issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Health Issues
S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, Substance Use Research Barriers to research resulting from DEA scheduling, Drug research related issues H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues Synthetic Fentanyl related issues Monitor Farm Bill 2023, Cannabidiol regulation
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2023 · third_quarter · Medical/Disease Research/Clinical Labs
Mental Health Substance Use Disorder related issues H.R.4531, SUPPORT Act, Reauthorization related issues Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) Monitor the following: H.R.467/S.1141, HALT Fentanyl Act, Entirety H.R.568, Save Americans from the Fentanyl Emergency (SAFE) Act, Entirety H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety 2023 Farm Bill, Cannabidiol related issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Health Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, Substance Use Research Barriers to research resulting from DEA scheduling, Drug research related issues H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues Synthetic Fentanyl related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2023 · second_quarter · Medical/Disease Research/Clinical Labs
H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety Mental Health Substance Use Disorder related issues SUPPORT Act, Reauthorization related issues H.R.467/S.1141, HALT Fentanyl Act, Entirety H.R.568, Save Americans from the Fentanyl Emergency (SAFE) Act, Entirety Monitor the following: Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) 2023 Farm Bill, Cannabidiol related issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Health Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, Substance Use Research Barriers to research resulting from DEA scheduling, Drug research related issues H.R.467, HALT Fentanyl Act, Drug use research related issues H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues Synthetic Fentanyl related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2023 · first_quarter · Medical/Disease Research/Clinical Labs
Monitor the following: Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) H.R.1359/S.644, Modernizing Opioid Treatment Access Act, Entirety 2023 Farm Bill, Cannabidiol related issues Mental Health Substance Use Disorder related issues SUPPORT Act, Reauthorization related issues H.R.467, HALT Fentanyl Act, Entirety H.R.568, Save Americans from the Fentanyl Emergency (SAFE) Act, Entirety
Client expense: Not reported · Firm income: $20,000
| Democratic |
| MN |
| Dan Newhouse | Republican | WA |
| Daniel T. Kildee | Democratic | MI |
| Derek Kilmer | Democratic | WA |
| Donald G. Davis | Democratic | NC |
| Jason Crow | Democratic | CO |
| Jennifer L. McClellan | Democratic | VA |
| Josh Harder | Democratic | CA |
| Maria Elvira Salazar | Republican | FL |
| Marie Gluesenkamp Perez | Democratic | WA |
| Michael Lawler | Republican | NY |
| Mike Levin | Democratic | CA |
| Nikki Budzinski | Democratic | IL |
| Seth Magaziner | Democratic | RI |
| Sharice Davids | Democratic | KS |
| Tony Gonzales | Republican | TX |
| HR 3629 |
118th |
| Related bill |
| HR 171 | 118th | Related bill |
| HR 1580 | 118th | Related bill |